StockNow
Log in
U.S. Markets

Amgen (AMGN) announces that its Repatha reduces the risk of death in patients at high risk of a first heart attack or stroke

StockNow breaking-news AI analysis

Amgen announced that Repatha reduces the risk of death in patients at high risk of a first heart attack or stroke.

1 stocks
AMGNAmgen Inc$432.92Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

IRGC says a supertanker caught fire and was halted after being struck by two naval mines in Strait of Hormuz, adds tanker was attempting to pass illegally through the Strait of Hormuz and that ships must comply with its rules for passage

Geopolitics

Iran's army said it launched tens of drones at the Al Minhad air base in the UAE